Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Global Acute Myeloid Leukemia (AML) Treatment Market US$ 1.17 Billion 2021The global acute myeloid leukemia treatment market expected to reach US$ 1.17 billion by 2021, growing at CAGR 15% over the forecast period, owing to introduction of high-priced products and strong pipeline of upcoming drugs.
In addition, the global acute myeloid leukemia treatment market report provides the detailed market landscape (market drivers, restraints, opportunities) Major players operating in the global acute myeloid leukemia treatment market and profiled in this report include Astellas Pharma, Astex Pharmaceuticals, Bayer, Boehringer Ingelheim, Celgene (Agios–Celgene) Visit Acute Myeloid Leukemia Treatment Market (https://www.ihealthcareanalyst.com/ 1. Drug Type 1.1. Hypomethylating Agents 1.1.1. Vidaza (Azacitidine) 1.1.2. Dacogen (Decitabine) 1.2. Cytarabine-based Chemotherapy Drugs 1.3. Others 2. Pipeline Analysis (Phase III Drugs) 2.1. Chemotherapy Drugs 2.2. Vyxeos (Fixed-combination Drugs: Daunorubicin and Cytarabine) 2.3. Kinase Inhibitors 2.3.1. Midostaurin 2.3.2. Quizartinib 3. Geography 3.1. North America (U.S., Canada) 3.2. Latin America (Brazil, Mexico, Rest of LA) 3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 3.4. Asia Pacific (Japan, China, India, Rest of APAC 3.5. Rest of the World 4. Company Profiles 4.1. Astellas Pharma 4.2. Astex Pharmaceuticals 4.3. Bayer 4.4. Boehringer Ingelheim 4.5. Celgene (Agios–Celgene) 4.6. Cyclacel Pharmaceuticals 4.7. Daiichi Sankyo 4.8. Jazz Pharmaceuticals 4.9. Novartis 4.10.Onyx Pharma 4.11.Otsuka Pharmaceuticals 4.12.Pfizer 4.13.Roche 4.14.Seattle Genetics 4.15.Sunesis Pharmaceuticals 4.16.Synta Pharmaceuticals To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client's specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|